Metrika članka

  • citati u SCindeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[=>]
  • posete u poslednjih 30 dana:3
  • preuzimanja u poslednjih 30 dana:3
članak: 1 od 1  
Vojnosanitetski pregled
2003, vol. 60, br. 4, str. 471-478
jezik rada: srpski
vrsta rada: neklasifikovan

Visceralna lajšmanijaza - patogenetske osnove kliničke raznolikosti
Vojnomedicinska akademija


Članak ne sadrži sažetak.

Ključne reči


Abbas, A.K., Murphy, K.M., Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature, 383(6603): 787-93
Aebischer, T. (1994) Recurrent cutaneous leishmaniasis: A role for persistent parasites?. Parasitol Today, 10(1): 25-8
Akuffo, H.O., Britton, S.F. (1992) Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans. Clin Exp Immunol, 87(1): 58-64
Andrews, N.W., Webster, P. (1991) Phagolysosomal escape by intracellular pathogens. Parasitol Today, 7(12): 335-40
Barcinski, M.A., Costa-Moreira, M.E. (1994) Cellular response of protozoan parasites to host-derived cytokines. Parasitol Today, 10(9): 352-5
Barral, A., Barral-Netto, M., Yong, E.C., Brownell, C.E., Twardzik, D.R., Reed, S.G. (1993) Transforming growth factor beta as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci USA, 90(8): 3442-6
Barral-Neto, M., Machado, P., Bittencourt, A., Barral, A. (1997) Recent advances in the pathophysiology and treatment of human cutaneous Leishmaniasis. Curr Opin Dermatol, 4, str. 51-8
Beverley, S.M., Turco, S.J. (1998) Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends Microbiol, 6(1): 35-40
Bogdan, C., Rollinghoff, M., Solbach, W. (1990) Evasion strategies of Leishmania parasites. Parasitol Today, 6(6): 183-7
Bray, R.S. (1983) Leishmania: Chemotaxic responses of promastigotes and macrophages in vitro. J Protozool, 30(2): 322-9
Brittingham, A., Morrison, C.J., McMaster, W.R., McGwire, B.S., Chang, K.P., Mosser, D.M. (1995) Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol, 155(6): 3102-11
Brittingham, A., Mosser, D.M. (2000) Exploatation of the complement system by Leishmania promastigotes. Parasitol Today, 12, str. 444-7
Buffet, P.A., Garin, Y.J., Sulahian, A., Nassar, N., Derouin, F. (1996) Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum. Ann Trop Med Parasitol, 90(3): 295-302
Cabrera, M., Shaw, M.A., Sharples, C., Williams, H., Castes, M., Convit, J., Blackwell, J.M. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med, 182(5): 1259-64
Caligaris-Cappio, F., Ferrarini, M. (1996) B cells and their fate in health and disease. Immunol Today, 17(5): 206-8
Cox, F.E.G., Liew, F.Y. (1992) T-cell subsets and cytokines in parasitic infections. Parasitol Today, 8, str. 371-4
da Silva, R.P., Hall, B.F., Joiner, K.A., Sacks, D.L. (1989) CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol, 143(2): 617-22
d'Ambrosio D., Iellem, A., Colantonio, L., Clissi, B., Pardi, R., Sinigaglia, F. (2000) Localization of Th-cell subsets in inflammation: Differential thresholds for extravasation of Th1 and Th2 cells. Immunol Today, 21(4): 183-6
Desjardins, M., Descoteaux, A. (1997) Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J Exp Med, 185(12): 2061-8
Desjeux, P. (1996) Leishmaniasis. Public health aspects and control. Clin Dermatol, 14(5): 417-23
Docampo, R., Moreno, S.N. (1999) Acidocalcisome: A novel Ca2+ storage compartment in trypanosomatids and apicomplexan parasites. Parasitol Today, 15(11): 443-8
Ebert, D., Herre, E.A. (1996) The evolution of parasitic diseases. Parasitol Today, 12(3): 96-101
Evans, T.G., Reed, S.S., Hibbs, J.B. (1996) Nitric oxide production in murine leishmaniasis: Correlation of progressive infection with increasing systemic synthesis of nitric oxide. Am J Trop Med Hyg, 54(5): 486-9
Fruth, U., Solioz, N., Louis, J.A. (1993) Leishmania major interferes with antigen presentation by infected macrophages. J Immunol, 150(5): 1857-64
Gorak, P.M., Engwerda, C.R., Kaye, P.M. (1998) Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection. Eur J Immunol, 28(2): 687-95
Gordon, S. (1985) Macrophage complement and lectin-like receptors bind Leishmania in the absence of serum. J Exp Med, 162(1): 324-31
Gradoni, L., Gramiccia, M. (1994) Leishmania infantum tropism: Strain genotype or host immune status?. Parasitol Today, 10(7): 264-7
Hall, B.F., Joiner, K.A. (1991) Strategies of obligate intracellular parasites for evading host defences. Immunol Today, 12(3): A22-7
Hall, L.R., Titus, R.G. (1995) Sand fly vector saliva selectively modulates macrophage functions that inhibit killing of Leishmania major and nitric oxide production. J Immunol, 155(7): 3501-6
Heinzel, F.P. (1994) Interleukin 12 and the regulation of CD4+ T-cell subset responses during murine Leishmaniasis. Parasitol Today, 10(5): 190-2
Hicks, S.J., Theodoropoulos, G., Carrington, S.D., Corfield, A.P. (2000) The role of mucins in host-parasite interactions. Part I-protozoan parasites. Parasitol Today, 16(11): 476-81
Ilg, T. (2000) Proteophosphoglycans of Leishmania. Parasitol Today, 16(11): 489-97
Jacobson, R.L., Doyle, R.J. (1996) Lectin-parasite interaction. Parasitol Today, 12, str. 55-61
Julia, V., Rassoulzadegan, M., Glaichenhaus, N. (1996) Resistance to Leishmania major induced by tolerance to a single antigen. Science, 274(5286): 421-3
Kamp, M. (1997) Regulator and effector functions of T-cell subsets in human Leishmanaia infections. APMIS Suppl, 105, str. 5-33
Kaufmann, S.H. (1993) Immunity to intracellular bacteria. Annu Rev Immunol, 11: 129-63
Kaye, P.M., Bancroft, G.J. (1992) Leishmania donovani infection in scid mice: Lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun, 60(10): 4335-42
Kemp, M., Hansen, M.B., Theander, T.G. (1992) Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals. Infect Immun, 60(6): 2246-51
Kemp, M., Kurtzhals, J.A., Kharazmi, A., Theander, T.G. (1994) Dichotomy in the human CD4+ T-cell response to Leishmania parasites. APMIS, 102(2): 81-8
Kima, P.E., Ruddle, N.H., McMahon-Pratt, D. (1997) Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells. J Immunol, 159(4): 1828-34
Kreutzer, R.D., Yemma, J.J., Grogl, M., Tesh, R.B., Martin, T.I. (1994) Evidence of sexual reproduction in the protozoan parasite Leishmania (Kinetoplastida: Trypanosomatidae). Am J Trop Med Hyg, 51(3): 301-7
Lanzer, M., Gross, U., Moll, H. (1997) Mechanisms of parasite persistence and immune evasion. Parasitol Today, 13, str. 1-3
Liew, F.Y., Li, Y., Millott, S. (1990) Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol, 145(12): 4306-10
Liew, F.Y. (1991) Role of cytokines in killing of intracellular pathogens. Immunol Lett, 30(2): 193-7
Lighthall, G.K., Giannini, S.H. (1992) The chromosomes of Leishmania. Parasitol Today, 8(6): 192-9
Liu, X., Chang, K.P. (1992) Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages. Proc Natl Acad Sci USA, 89(11): 4991-5
Lucey, D.R., Clerici, M., Shearer, G.M. (1996) Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases. Clin Microbiol Rev, 9(4): 532-62
Mattner, F., Alber, G., Magram, J., Kopf, M. (1997) The role of IL-12 and IL-4 in Leishmania major infection. Chem Immunol, 68: 86-109
McSorley, S., Proudfoot, L., O'Donnell, C.A., Liew, F.Y. (1996) Immunology of murine leishmaniasis. Clin Dermatol, 14(5): 451-64
Meeusen, E.N., Premier, R.R., Brandon, M.R. (1996) Tissue-specific migration of lymphocytes: A key role for Th1 and Th2 cells?. Immunol Today, 17(9): 421-4
Melby, P.C. (1991) Experimental leishmaniasis in humans: Review. Rev Infect Dis, 13(5): 1009-17
Mosmann, T.R., Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today, 17(3): 138-46
Mosmann, T.R., Moore, K.W. (1991) The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today, 12(3): A49-53
Mosser, D.M., Edelson, P.J. (1987) The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature, 327(6120): 329-31
Mosser, D.M., Rosenthal, L.A. (1993) Leishmania-macrophage interactions: Multiple receptors, multiple ligands and diverse cellular responses. Semin Cell Biol, 4(5): 315-22
Mosser, D.M., Springer, T.A., Diamond, M.S. (1992) Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18). J Cell Biol, 116(2): 511-20
Mosser, D.M. (1984) Activation of the alternative complement pathway by Leishmania promastigotes: Parasite lysis and attachment to macrophages. J Immunol, 132(3): 1501-5
Noben-Trauth, N., Kropf, P., Muller, I. (1996) Susceptibility to Leishmania major infection in interleukin-4-deficient mice. Science, 271(5251): 987-90
Overath, P., Aebischer, T. (1999) Antigen presentation by macrophages harboring intravesicular pathogens. Parasitol Today, 15(8): 325-32
Pinelli, E., Killick-Kendrick, R., Wagenaar, J., Bernadina, W., del Real, G., Ruitenberg, J. (1994) Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect Immun, 62(1): 229-35
Pirmez, C., Yamamura, M., Uyemura, K., Paes-Oliveira, M., Conceicao-Silva, F., Modlin, R.L. (1993) Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest, 91(4): 1390-5
Proudfoot, L., O'Donnell, C.A., Liew, F.Y. (1995) Glycoinositolphospholipids of Leishmania major inhibit nitric oxide synthesis and reduce leishmanicidal activity in murine macrophages. Eur J Immunol, 25(3): 745-50
Quaranta, J.F., Marty, P., Suffia, I., Menezes, N., Eulalto, M.C., Lelievre, A., le Fichoux, Y., i dr. (1995) The role of cytokines and cells: Immunopathology of Leishmaniasis, the role of cytokines and cells Th1/Th2. Med Chir Dig, 24, str. 203-6.(in French)
Reiner, S.L., Wang, Z.E., Hatam, F., Scott, P., Locksley, R.M. (1993) TH1 and TH2 cell antigen receptors in experimental leishmaniasis. Science, 259(5100): 1457-60
Reiner, S.L. (1994) Parasites and T helper cell development: Some insights. Parasitol Today, 10(12): 485-8
Reiner, S.L., Locksley, R.M. (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol, 13: 151-77
Reiner, S.L., Zheng, S., Wang, Z.E., Stowring, L., Locksley, R.M. (1994) Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection. J Exp Med, 179(2): 447-56
Requena, J.M., Alonso, C., Soto, M. (2000) Evolutionarily conserved proteins as prominent immunogens during Leishmania infections. Parasitol Today, 16(6): 246-50
Rittig, M.G., Bogdan, C. (2000) Leishmania-host-cell interaction: Complexities and alternative views. Parasitol Today, 16(7): 292-7
Rittig, M.G., Wilske, B., Krause, A. (1999) Phagocytosis of microorganisms by means of overshooting pseudopods: Where do we stand?. Microbes Infect, 1(9): 727-35
Romagnani, S. (1992) Induction of TH1 and TH2 responses: A key role for the 'natural' immune response?. Immunol Today, 13(10): 379-81
Romagnani, S. (1997) The Th1/Th2 paradigm. Immunol Today, 18(6): 263-6
Ross, G.D., Medof, M.E. (1985) Membrane complement receptors specific for bound fragments of C3. Adv Immunol, 37: 217-67
Russell, D.G. (1987) The macrophage-attachment glycoprotein gp63 is the predominant C3-acceptor site on Leishmania mexicana promastigotes. Eur J Biochem, 164(1): 213-21
Sadick, M.D., Heinzel, F.P., Holaday, B.J., Pu, R.T., Dawkins, R.S., Locksley, R.M. (1990) Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med, 171(1): 115-27
Scharton, T.M., Scott, P. (1993) Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice. J Exp Med, 178(2): 567-77
Scharton-Kersten, T., Afonso, L.C., Wysocka, M., Trinchieri, G., Scott, P. (1995) IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J Immunol, 154(10): 5320-30
Schmid-Hempel, P., Koella, J.C. (1994) Variability and its implications for host-parasite interactions. Parasitol Today, 10(3): 98-102
Scott, P. (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol, 147(9): 3149-55
Stenger, S., Donhauser, N., Thuring, H., Rollinghoff, M., Bogdan, C. (1996) Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase. J Exp Med, 183(4): 1501-14
Sutterwala, F.S., Rosenthal, L.A., Mosser, D.M. (1996) Cooperation between CR1 (CD35) and CR3 (CD 11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol, 59(6): 883-90
Svobodova, M., Volf, P., Killick-Kendrick, R. (1996) Agglutination of Leishmania promastigotes by midgut lectins from various species of phlebotomine sandflies. Ann Trop Med Parasitol, 90(3): 329-36
Traub-Cseko, Y.M., Momen, H. (1995) On chagas disease and leishmaniasis. Parasitol Today, 11, str. 315-7
Trinchieri, G. (1993) Interleukin-12 and its role in the generation of TH1 cells. Immunol Today, 14(7): 335-8
Turco, S.J., Spath, G.F., Beverley, S.M. (2001) Is lipophosphoglycan a virulence factor? A surprising diversity between Leishmania species. Trends Parasitol, 17(5): 223-6
Turco, S.J., Descoteaux, A. (1992) The lipophosphoglycan of Leishmania parasites. Annu Rev Microbiol, 46: 65-94
Turco, S.J. (1988) The lipophosphoglycan of Leishmania. Parasitol Today, 4(9): 255-7
Vidal, S.M., Malo, D., Vogan, K., Skamene, E., Gros, P. (1993) Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell, 73(3): 469-85
Vieira, L.Q., Goldschmidt, M., Nashleanas, M., Pfeffer, K., Mak, T., Scott, P. (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol, 157(2): 827-35
Waitumbi, J., Warburg, A. (1998) Phlebotomus papatasi saliva inhibits protein phosphatase activity and nitric oxide production by murine macrophages. Infect Immun, 66(4): 1534-7
Weigle, K., Saravia, N.G. (1996) Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous Leishmaniasis. Clin Dermatol, 14(5): 433-50
Wilson, M.E., Streit, J.A. (1996) Visceral leishmaniasis. Gastroenterol Clin North Am, 25(3): 535-51
Zilberstein, D., Shapira, M. (1994) The role of pH and temperature in the development of Leishmania parasites. Annu Rev Microbiol, 48: 449-70